Using various methods to increase the secretion of GLP-1 may provide alternative therapeutic options to treat metabolic disorders such as obesity, diabetes, and NAFLD which may be due to the lack of GLP-1. Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.